Advanced Search
Contact | Corporate | Help

Proton Therapy and Bevacizumab for Primary Liver Tumors

Sponsors:
  • M.D. Anderson Cancer Center
  • Genentech
Phases:
  • Phase I
IndicationsAcronym:
  • Liver Cancer
  • Hepatocellular Carcinoma
  • Cholangiocarcinoma
Age Groups:
  • Child
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Bevacizumab
  • Radiation: Proton Radiation Therapy
Enrollment:
3

Additional information about NCT00426829.


SourceSolution © 2008-2012